BIA thanks UK public for supporting biomedical research

bia-steve-bates web The BioIndustry Association (BIA) plans a series of events designed to thank the British public for its support of biomedical research through charity funding.

The events form part of the first European Biotech Week (30 Sept–4 Oct 2013), in which 20 biotechnology associations will highlight the sector’s achievements and opportunities.

Medical research charities in the UK fund over £1bn of research each year, with biotechnology at the cutting edge of drug and diagnostic discovery.

The week celebrates the 60th anniversary of the publication of the double helix structure of the DNA molecule – the basis of genetic science.

Steve Bates, CEO of the BIA, said: “The UK public are the most generous in Europe in their support for biomedical research through charity donation. It’s great for the biotech sector in the UK to know they have the support of the British public as scientists seek to develop the next generation of medical therapies.

“We want to thank the public for their support and share with them some of the research which their money is spent on.”

Planned events include:

• On 4 October the BIA will collaborate with the British Heart Foundation (BHF), Babraham Institute researchers and staff from Papworth Hospital (a specialist centre for cardiothoracic treatment) to share new discoveries in cardiovascular science and healthy lifestyle tips at the Peterborough BHF shop.

• On 27 September Jim Paice MP will visit Cambridge-based firm Arecor and take part in a round-table discussion with biotech companies about how the UK government can support the sector.

• On 2 October two UK biotech SMEs, e-Therapeutics and PsiOxus Therapeutics, are among the shortlisted companies that may receive the 2013 EuropaBio Most Innovative EU Biotech SME award in Brussels, with a prize of €10,000.